×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Gengos Andrew

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ATHAAthira Pharma, Inc.Gengos AndrewCFO AND CHIEF BUSINESS OFFICERJan 05, 2024Sale$2.911,2083,51583,804Feb 16, 2024, 04:34 PM
ATHAAthira Pharma, Inc.Gengos AndrewSee BelowJan 05, 2023Sale$2.911,2083,51583,804Jan 08, 2024, 04:42 PM
ATHAAthira Pharma, Inc.Gengos AndrewSee BelowJun 07, 2023Buy$3.4315,00051,44580,012Jun 09, 2023, 05:06 PM
ATHAAthira Pharma, Inc.Gengos AndrewSee BelowJun 02, 2023Buy$2.8220,01256,42220,012Jun 06, 2023, 07:36 PM
ATHAAthira Pharma, Inc.Gengos AndrewSee BelowJun 05, 2023Buy$3.0045,000135,15065,012Jun 06, 2023, 07:36 PM
IMUCImmunoCellular Therapeutics, Ltd.Gengos AndrewDirectorDec 31, 2016Option Exercise$2.053,2846,7325,249Feb 13, 2017, 04:04 PM
IMUCImmunoCellular Therapeutics, Ltd.Gengos AndrewPresident and CEONov 30, 2015Buy$0.4410,0004,35047,000Dec 02, 2015, 07:43 PM
IMUCImmunoCellular Therapeutics, Ltd.Gengos AndrewPresident and CEOFeb 18, 2015Buy$0.6041,33324,80078,333Feb 20, 2015, 06:36 PM
IMUCImmunoCellular Therapeutics, Ltd.Gengos AndrewPresident and CEOAug 14, 2014Buy$0.9010,0008,99437,000Aug 14, 2014, 05:38 PM
IMUCImmunoCellular Therapeutics, Ltd.Gengos AndrewPresident and CEODec 18, 2013Buy$0.7227,00019,36227,000Dec 18, 2013, 12:49 PM